APA (7th ed.) Citation

H, T., MP, V., O, A., S, Y., D, G., H, O., . . . ŞK, G. (2026). Cardiotoxicity perspective on the concurrent use of anti-HER2 agents and hypofractionated versus conventional fractionated locoregional radiotherapy in breast cancer. BMC cancer, 26(1), . https://doi.org/10.1186/s12885-026-16160-6

Chicago Style (17th ed.) Citation

H, Tepetam, Varan MP, Alomarı O, Yıldırım S, Gedik D, Odabaş H, Yaprak G, Taşlıyurt Ö, and Gül ŞK. "Cardiotoxicity Perspective on the Concurrent Use of Anti-HER2 Agents and Hypofractionated Versus Conventional Fractionated Locoregional Radiotherapy in Breast Cancer." BMC Cancer 26, no. 1 (2026). https://doi.org/10.1186/s12885-026-16160-6.

MLA (9th ed.) Citation

H, Tepetam, et al. "Cardiotoxicity Perspective on the Concurrent Use of Anti-HER2 Agents and Hypofractionated Versus Conventional Fractionated Locoregional Radiotherapy in Breast Cancer." BMC Cancer, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12885-026-16160-6.